Literature DB >> 30323021

H2S, a Bacterial Defense Mechanism against the Host Immune Response.

Tracy Toliver-Kinsky1,2, Weihua Cui3, Gabor Törö3, Seung-Jin Lee3, Konstantin Shatalin4, Evgeny Nudler4, Csaba Szabo3,2,5.   

Abstract

The biological mediator hydrogen sulfide (H2S) is produced by bacteria and has been shown to be cytoprotective against oxidative stress and to increase the sensitivity of various bacteria to a range of antibiotic drugs. Here we evaluated whether bacterial H2S provides resistance against the immune response, using two bacterial species that are common sources of nosocomial infections, Escherichia coli and Staphylococcus aureus Elevations in H2S levels increased the resistance of both species to immune-mediated killing. Clearances of infections with wild-type and genetically H2S-deficient E. coli and S. aureus were compared in vitro and in mouse models of abdominal sepsis and burn wound infection. Also, inhibitors of H2S-producing enzymes were used to assess bacterial killing by leukocytes. We found that inhibition of bacterial H2S production can increase the susceptibility of both bacterial species to rapid killing by immune cells and can improve bacterial clearance after severe burn, an injury that increases susceptibility to opportunistic infections. These findings support the role of H2S as a bacterial defense mechanism against the host response and implicate bacterial H2S inhibition as a potential therapeutic intervention in the prevention or treatment of infections.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antibiotic resistance; burn; hydrogen sulfide; opportunistic infections

Mesh:

Substances:

Year:  2018        PMID: 30323021      PMCID: PMC6300618          DOI: 10.1128/IAI.00272-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  ROS production in phagocytes: why, when, and where?

Authors:  Sophie Dupré-Crochet; Marie Erard; Oliver Nüβe
Journal:  J Leukoc Biol       Date:  2013-04-22       Impact factor: 4.962

Review 2.  A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.

Authors:  Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-09-22       Impact factor: 5.858

3.  Inhibition of hydrogen sulfide production by gene silencing attenuates inflammatory activity of LPS-activated RAW264.7 cells.

Authors:  Alireza Badiei; Jack Rivers-Auty; Abel Damien Ang; Madhav Bhatia
Journal:  Appl Microbiol Biotechnol       Date:  2013-07-10       Impact factor: 4.813

4.  Hydrogen sulfide is an endogenous regulator of aging in Caenorhabditis elegans.

Authors:  Bedoor Qabazard; Ling Li; Jan Gruber; Meng Teng Peh; Li Fang Ng; Srinivasan Dinesh Kumar; Peter Rose; Choon-Hong Tan; Brian W Dymock; Feng Wei; Suresh C Swain; Barry Halliwell; Stephen R Stürzenbaum; Philip K Moore
Journal:  Antioxid Redox Signal       Date:  2013-11-21       Impact factor: 8.401

Review 5.  Enzymology of H2S biogenesis, decay and signaling.

Authors:  Omer Kabil; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2013-06-07       Impact factor: 8.401

6.  Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.

Authors:  Ling Li; Matthew Whiteman; Yan Yi Guan; Kay Li Neo; Yvonne Cheng; Shiau Wei Lee; Yujun Zhao; Rajamanian Baskar; Choon-Hong Tan; Philip K Moore
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

7.  Interactions of hydrogen sulfide with myeloperoxidase.

Authors:  Zoltán Pálinkás; Paul G Furtmüller; Attila Nagy; Christa Jakopitsch; Katharina F Pirker; Marcin Magierowski; Katarzyna Jasnos; John L Wallace; Christian Obinger; Péter Nagy
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

8.  Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days.

Authors:  Daniel G Remick; Gerald R Bolgos; Javed Siddiqui; Jungsoon Shin; Jean A Nemzek
Journal:  Shock       Date:  2002-06       Impact factor: 3.454

9.  Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).

Authors:  Antonia Asimakopoulou; Panagiotis Panopoulos; Christos T Chasapis; Ciro Coletta; Zongmin Zhou; Giuseppe Cirino; Athanassios Giannis; Csaba Szabo; Georgios A Spyroulias; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Authors:  Nadiya Druzhyna; Bartosz Szczesny; Gabor Olah; Katalin Módis; Antonia Asimakopoulou; Athanasia Pavlidou; Petra Szoleczky; Domokos Gerö; Kazunori Yanagi; Gabor Törö; Isabel López-García; Vassilios Myrianthopoulos; Emmanuel Mikros; John R Zatarain; Celia Chao; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Pharmacol Res       Date:  2016-08-10       Impact factor: 7.658

View more
  19 in total

Review 1.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

2.  Enhancement of the Bactericidal Effect of Antibiotics by Inhibition of Enzymes Involved in Production of Hydrogen Sulfide in Bacteria.

Authors:  T A Seregina; K V Lobanov; R S Shakulov; A S Mironov
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

Review 3.  Emerging roles of cystathionine β-synthase in various forms of cancer.

Authors:  Kelly Ascenção; Csaba Szabo
Journal:  Redox Biol       Date:  2022-05-10       Impact factor: 10.787

4.  Nanoparticle-Enabled Combination Therapy Showed Superior Activity against Multi-Drug Resistant Bacterial Pathogens in Comparison to Free Drugs.

Authors:  Amarpreet Brar; Satwik Majumder; Maria Zardon Navarro; Marie-Odile Benoit-Biancamano; Jennifer Ronholm; Saji George
Journal:  Nanomaterials (Basel)       Date:  2022-06-24       Impact factor: 5.719

Review 5.  H2S and reactive sulfur signaling at the host-bacterial pathogen interface.

Authors:  Brenna J C Walsh; David P Giedroc
Journal:  J Biol Chem       Date:  2020-07-22       Impact factor: 5.157

6.  Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts.

Authors:  Theodora Panagaki; Elisa B Randi; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-23

7.  The Response of Acinetobacter baumannii to Hydrogen Sulfide Reveals Two Independent Persulfide-Sensing Systems and a Connection to Biofilm Regulation.

Authors:  Brenna J C Walsh; Jiefei Wang; Katherine A Edmonds; Lauren D Palmer; Yixiang Zhang; Jonathan C Trinidad; Eric P Skaar; David P Giedroc
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

8.  Proteomics Profiling of S-sulfurated Proteins in Acinetobacter baumannii.

Authors:  Brenna J C Walsh; David P Giedroc
Journal:  Bio Protoc       Date:  2021-05-05

9.  Diversity and Adaptations of Escherichia coli Strains: Exploring the Intestinal Community in Crohn's Disease Patients and Healthy Individuals.

Authors:  Maria N Siniagina; Maria I Markelova; Eugenia A Boulygina; Alexander V Laikov; Dilyara R Khusnutdinova; Sayar R Abdulkhakov; Natalia A Danilova; Alfiya H Odintsova; Rustam A Abdulkhakov; Tatyana V Grigoryeva
Journal:  Microorganisms       Date:  2021-06-15

10.  Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response.

Authors:  Monica Sueiro-Olivares; Jennifer Scott; Sara Gago; Dunja Petrovic; Emilia Kouroussis; Jasmina Zivanovic; Yidong Yu; Marlene Strobel; Cristina Cunha; Darren Thomson; Rachael Fortune-Grant; Sina Thusek; Paul Bowyer; Andreas Beilhack; Agostinho Carvalho; Elaine Bignell; Milos R Filipovic; Jorge Amich
Journal:  PLoS Biol       Date:  2021-06-01       Impact factor: 9.593

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.